← FDA ENFORCEMENT
D-0549-2024Class II

RemedyRepack Inc.

What this record is not

A recall record is reproduced as FDA published it, and the classification is FDA’s. SPEQ adds no interpretation, and a recall concerns the products and dates in the record — it is not a statement about a company’s other products or its current status.

Recalling firm
RemedyRepack Inc.
Product type
Drug
Status
Terminated
Report date
2024-06-19
Distribution
Product was distributed to one medical facility.
Firm state
PA
Product quantity
8 bottles
Initiated by
Voluntary: Firm initiated
Reason for recall

Product Mix Up. A bottle labeled as Phenazopyridine HCl tablets USP 100 mg contained Phenobarbital tablets 16.2 mg.

Product description

Phenazopyridine HCl, 100mg tablets, 6 count bottles, Rx Only, Repackaged by: RemedyRepack, Inc., Indiana, PA NDC#: 70518-0218-00, Source NDC: 75826-0114-10 MFG: Winder Laboratories, LLC, Winder, GA

Code / lot info

Lot # B2906961-042524, exp. date 02/26/2027

Data: U.S. FDA. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification. Open the enforcement explorer →